Prednisonum [Inn-Latin]

Prednisonum [Inn-Latin] Brand names, Prednisonum [Inn-Latin] Analogs

Prednisonum [Inn-Latin] Brand Names Mixture

Cortab (Biotin + Chlorpheniramine Maleate + D-Pantothenic Acid + Inositol + Nicotinic Acid + Prednisone + Pyridoxine Hydrochloride + Thiamine Mononitrate + Vitamin a + Vitamin B2 + Vitamin D + Vitamin E (Dl-Alpha Tocopheryl Acetate))
Metreton Tab (Chlorpheniramine Maleate + Prednisone + Vitamin C)
Predniderm Tab (Inositol + Pheniramine Maleate + Phosphatidyl Choline + Prednisone + Vitamin a + Vitamin D2 + Vitamin E)
Sterolin Liq (Biotin + Fatty Acids Unsaturated + Inositol + Nicotinic Acid + Pheniramine Maleate + Phosphatidyl Choline + Prednisone + Vitamin a Palmitate + Vitamin B2 + Vitamin D2 + Vitamin E)

Prednisonum [Inn-Latin] Chemical_Formula

C₂₁H₂₆O₅

Prednisonum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/pred.htm

Prednisonum [Inn-Latin] fda sheet

Prednisonum [Inn-Latin] msds (material safety sheet)

Prednisonum_[Inn-Latin] MSDS

Prednisonum [Inn-Latin] Synthesis Reference

Oliveto, Gould, U.S. Pat. 2,897,216 (1959)

Prednisonum [Inn-Latin] Molecular Weight

358.428 g/mol

Prednisonum [Inn-Latin] Melting Point

233 - 235 ^oC

Prednisonum [Inn-Latin] H₂O Solubility

312 mg/L

Prednisonum [Inn-Latin] State

Solid

Prednisonum [Inn-Latin] LogP

1.471

Prednisonum [Inn-Latin] Dosage Forms

Tablets; Ointments; Cream; Oral Solution

Prednisonum [Inn-Latin] Indication

Systemic use: for the treatment of drug-induced allergic reactions, perennial or seasonal allergic rhinitis, serum sickness, giant cell arteritis acute rheumatic or nonrheumatic carditis, systemic dermatomyositis, systemic lupus erythematosus, atopic dermatitis, contact dermatitis, exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe (Stevens-Johnson syndrome) erythema multiforme, mycosis fungoides, pemphigus, severe psoriasis, acute adrenocortical insufficiency, Addison's disease, secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with neoplasms, nonsuppurative thyroiditis, ulceratice colitis, Crohn's disease, acquired hemolytic anemia, congenital hypoplastic anemia, erythroblastopenia, adult secondary thrombocytopenia, adult idiopathic thrombocytopenia purpura, acute or subacute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute or chronic lymphocytic leukemia, Hodgkin's or non-Hodgkin's lynphomas, Waldenstrom's macroglobulinemia, primary brain tumors (adjunct), nephrotic syndrome, tuberculous meningitis, multiple sclerosis, myasthenia gravis. cerebral edema, chorioretinitis, diffuse posterior choroiditis, aleergic conjunctivitis, Herpes zoster ophthalmicus, anterior segment inflammation, iridocyclitis, iritis, keratitis, optoc neuritis, sympathetic ophthalmia, corneal marginal allergic ulcers, symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy and aspiration pneumonitis.

Prednisonum [Inn-Latin] Pharmacology

Prednisone, the most commonly-prescribed corticosteroid, is used to treat allograft rejection, asthma, systemic lupus erythematosus, and many other inflammatory states. Prednisone has very little mineralocorticoid activity.

Prednisonum [Inn-Latin] Absorption

Readily absorbed from the gastrointestinal tract.

Prednisonum [Inn-Latin] side effects and Toxicity

LD₅₀=mg/kg (orally in rat)

Prednisonum [Inn-Latin] Patient Information

Persons who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chicken pox or measles. Patients should also be advised if they are exposed, medical advice should be sought without delay.

Prednisonum [Inn-Latin] Organisms Affected

Humans and other mammals